{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:49:34Z","timestamp":1793108974183,"version":"4.5.0"},"reference-count":33,"publisher":"Edizioni Minerva Medica","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Minerva Cardioangiol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.23736\/s0026-4725.19.04891-6","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T14:48:56Z","timestamp":1554821336000},"source":"Crossref","is-referenced-by-count":14,"title":["Recurrent retinal vein thrombosis: prevention with Aspirin, Pycnogenol\u00ae, ticlopidine, or sulodexide"],"prefix":"10.23736","volume":"67","author":[{"given":"Gianni","family":"Belcaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Dugall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh D.","family":"Bradford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria R.","family":"Cesarone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Feragalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Gizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Cotellese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morio","family":"Hosoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17149","reference":[{"key":"10.23736\/S0026-4725.19.04891-6_ref001","unstructured":"Porter RS, Kaplan LJ. The Merck Manual of diagnosis and therapy. Whitehouse Station, NJ: Merck, Sharp &amp; Dohme; 2011."},{"key":"10.23736\/S0026-4725.19.04891-6_ref002","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(83)34530-9"},{"key":"10.23736\/S0026-4725.19.04891-6_ref003","unstructured":"Belcaro G, Agus GB, Agus MA, Arpaia G, Bavera PM, Bottari A, et al. Trombosi venose ed embolie. Prevenzione e trattamento. Turin: Edizioni Minerva Medica; 2014."},{"key":"10.23736\/S0026-4725.19.04891-6_ref004","doi-asserted-by":"publisher","DOI":"10.1080\/02713680701851902"},{"key":"10.23736\/S0026-4725.19.04891-6_ref005","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.01.060"},{"key":"10.23736\/S0026-4725.19.04891-6_ref006","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2010.12.012"},{"key":"10.23736\/S0026-4725.19.04891-6_ref007","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e31825dd2a7"},{"key":"10.23736\/S0026-4725.19.04891-6_ref008","doi-asserted-by":"publisher","DOI":"10.1586\/eop.11.59"},{"key":"10.23736\/S0026-4725.19.04891-6_ref009","first-page":"CD007324","article-title":"Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion","volume":"1","author":"Gewaily D","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.23736\/S0026-4725.19.04891-6_ref010","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.234"},{"key":"10.23736\/S0026-4725.19.04891-6_ref011","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.233"},{"key":"10.23736\/S0026-4725.19.04891-6_ref012","unstructured":"Belcaro G, Cornelli U, Dugall M, Luzzi R, Hosoi M, Ledda A, et al. Panel 2013 Supplements and green drugs studies. New rules 2013. London and Annecy Panel. Angiology Online 2012"},{"key":"10.23736\/S0026-4725.19.04891-6_ref013","first-page":"I","article-title":"Assessment of nutraceuticals and food supplements","volume":"53","author":"Belcaro G","year":"2011","journal-title":"Panminerva Med"},{"key":"10.23736\/S0026-4725.19.04891-6_ref014","doi-asserted-by":"publisher","DOI":"10.1177\/107424840200700101"},{"key":"10.23736\/S0026-4725.19.04891-6_ref015","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1177\/000331970105202S01","article-title":"A new role for natural drugs in cardiovascular medicine","volume":"52","author":"Belcaro G","year":"2001","journal-title":"Angiology"},{"key":"10.23736\/S0026-4725.19.04891-6_ref016","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2013.09.006"},{"key":"10.23736\/S0026-4725.19.04891-6_ref017","doi-asserted-by":"publisher","DOI":"10.1177\/1076029614533143"},{"key":"10.23736\/S0026-4725.19.04891-6_ref018","doi-asserted-by":"publisher","DOI":"10.1177\/000331970405500302"},{"key":"10.23736\/S0026-4725.19.04891-6_ref019","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(83)34530-9"},{"key":"10.23736\/S0026-4725.19.04891-6_ref020","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.07.017"},{"key":"10.23736\/S0026-4725.19.04891-6_ref021","doi-asserted-by":"publisher","DOI":"10.1159\/000213640"},{"key":"10.23736\/S0026-4725.19.04891-6_ref022","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.5019"},{"key":"10.23736\/S0026-4725.19.04891-6_ref023","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2010.04.009"},{"key":"10.23736\/S0026-4725.19.04891-6_ref024","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2007.07.002"},{"key":"10.23736\/S0026-4725.19.04891-6_ref025","doi-asserted-by":"publisher","DOI":"10.1177\/107602960401000410"},{"key":"10.23736\/S0026-4725.19.04891-6_ref026","first-page":"316","article-title":"Does pycnogenol intensify the efficacy of acetylsalicylic acid in the inhibition of platelet function? In vitro experience","volume":"60","author":"Gola\u0144ski J","year":"2006","journal-title":"Postepy Hig Med Dosw"},{"key":"10.23736\/S0026-4725.19.04891-6_ref027","unstructured":"Natural medication reduces DVT risk. Health News 2005;11:14."},{"key":"10.23736\/S0026-4725.19.04891-6_ref028","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2007.0108"},{"key":"10.23736\/S0026-4725.19.04891-6_ref029","first-page":"S35","article-title":"Treatment of retinal vein thrombosis with pentoxifylline: a controlled, randomized trial","volume":"53","author":"De Sanctis MT","year":"2002","journal-title":"Angiology"},{"key":"10.23736\/S0026-4725.19.04891-6_ref030","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-199616060-00008"},{"key":"10.23736\/S0026-4725.19.04891-6_ref031","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.06.061"},{"key":"10.23736\/S0026-4725.19.04891-6_ref032","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1996.01100140443012"},{"key":"10.23736\/S0026-4725.19.04891-6_ref033","first-page":"238","article-title":"Prevention of recurrent venous thrombosis and post-thrombotic syndrome","volume":"66","author":"Belcaro G","year":"2018","journal-title":"Minerva Cardioangiol"}],"container-title":["Minerva Cardioangiologica"],"original-title":[],"link":[{"URL":"https:\/\/www.minervamedica.it\/pdf.php?cod=R05Y2019N02A0109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T09:07:21Z","timestamp":1569920841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.minervamedica.it\/index2.php?show=R05Y2019N02A0109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":33,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.23736\/s0026-4725.19.04891-6","relation":{},"ISSN":["0026-4725","1827-1618"],"issn-type":[{"value":"0026-4725","type":"print"},{"value":"1827-1618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}